Revision of the Synthesis and Pharmacological Activity of a Reported Translation Inhibitor

Author(s): Christine Basmadjian, Helene Malka-Mahieu, Laurent Desaubry

Journal Name: Anti-Cancer Agents in Medicinal Chemistry
(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)

Volume 15 , Issue 10 , 2015

Become EABM
Become Reviewer

Graphical Abstract:


4EGI-1 is the prototype of a novel class of anticancer agents targeting translation. Patented drug-like analogue 1 was synthesized and examined for inhibition of translation and cytotoxicity in cancer cells. Unexpectedly, 1 was found inactive in both assays.

Keywords: Cancer, eIF4E, metastatic melanoma, mRNA translation, protein synthesis, thiazoles.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Published on: 07 October, 2015
Page: [1305 - 1307]
Pages: 3
DOI: 10.2174/1871520615666150602092450
Price: $65

Article Metrics

PDF: 17